Adaptive Biotechnologies Corporation · NASDAQ:ADPT
Piskel Kyle sold 3,115 Adaptive Biotechnologies Corporation shares (Form 4)
Traded May 18, 2026 · Filed May 20, 2026
On May 18, 2026, Piskel Kyle (Chief Financial Officer) sold 3,115 Adaptive Biotechnologies Corporation shares at US$13.04 for US$40,620, leaving 256,725 shares. Filed May 20, 2026 (Form 4).
- Sold
- 3,115 shares
- Price
- US$13.04
- Value
- US$40,620
- Holding after
- 256,725 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 18, 2026 | Common Stock | Sale | 3,115 | US$13.04 | 256,725 | Direct |